NCT06506292
- Conditions
- Adebrelimab (SHR-1316), GC/GEJC, XELOX
- Locations
-
- Tianjin Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
XELOX
Explore clinical trials studying XELOX. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study